New drug aims to fix chemo side effect that delays cancer care
NCT ID NCT06456528
First seen Jan 12, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This study tests a drug called QL0911 for cancer patients whose platelet levels drop too low due to chemotherapy. Low platelets can delay treatment or require dose changes. The trial will see if QL0911 safely raises platelet counts so patients can complete their chemo on schedule. About 235 adults aged 18-75 with certain cancers are being recruited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Harbin First Hospital
RECRUITINGHarbin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nanjing Tianyinshan Hospital
RECRUITINGNanjing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.